| Minimal residual disease prior to allogeneic hematopoietic cell transplantation in acute myeloid leukemia: a meta-analysis SA Buckley, BL Wood, M Othus, CS Hourigan, C Ustun, MA Linden, ... haematologica 102 (5), 865, 2017 | 253 | 2017 |
| Novel targeted deregulation of c-Myc cooperates with Bcl-XL to cause plasma cell neoplasms in mice WC Cheung, JS Kim, M Linden, L Peng, B Van Ness, RD Polakiewicz, ... The Journal of clinical investigation 113 (12), 1763-1773, 2004 | 143 | 2004 |
| The comparative diagnostic features of canine and human lymphoma DM Seelig, AC Avery, EJ Ehrhart, MA Linden Veterinary sciences 3 (2), 11, 2016 | 126 | 2016 |
| Gene profiling of a myeloma cell line reveals similarities and unique signatures among IL-6 response, N-ras-activating mutations, and coculture with bone marrow stromal cells PA Croonquist, MA Linden, F Zhao, BG Van Ness Blood 102 (7), 2581-2592, 2003 | 98 | 2003 |
| Profiling bortezomib resistance identifies secondary therapies in a mouse myeloma model HAF Stessman, LB Baughn, A Sarver, T Xia, R Deshpande, A Mansoor, ... Molecular cancer therapeutics 12 (6), 1140-1150, 2013 | 90 | 2013 |
| Myeloablative, but not reduced-intensity, conditioning overcomes the negative effect of flow-cytometric evidence of leukemia in acute myeloid leukemia C Ustun, EL Courville, T DeFor, M Dolan, N Randall, S Yohe, N Bejanyan, ... Biology of Blood and Marrow Transplantation 22 (4), 669-675, 2016 | 67 | 2016 |
| Targeted overexpression of Bcl-XL in B-lymphoid cells results in lymphoproliferative disease and plasma cell malignancies M Linden, N Kirchhof, C Carlson, B Van Ness Blood 103 (7), 2779-2786, 2004 | 57 | 2004 |
| Reduced CXCR4 expression is associated with extramedullary disease in a mouse model of myeloma and predicts poor survival in multiple myeloma patients treated with bortezomib HAF Stessman, A Mansoor, F Zhan, S Janz, MA Linden, LB Baughn, ... Leukemia 27 (10), 2075-2077, 2013 | 53 | 2013 |
| Single-cell gene expression analyses reveal distinct self-renewing and proliferating subsets in the leukemia stem cell compartment in acute myeloid leukemia K Sachs, AL Sarver, KE Noble-Orcutt, RS LaRue, ML Antony, D Chang, ... Cancer research 80 (3), 458-470, 2020 | 51 | 2020 |
| Chronic liver injury alters driver mutation profiles in hepatocellular carcinoma in mice JD Riordan, CR Feddersen, BR Tschida, PJ Beckmann, VW Keng, ... Hepatology 67 (3), 924-939, 2018 | 41 | 2018 |
| Sleeping Beauty Insertional Mutagenesis in Mice Identifies Drivers of Steatosis-Associated Hepatic Tumors BR Tschida, NA Temiz, TP Kuka, LA Lee, JD Riordan, CA Tierrablanca, ... Cancer research 77 (23), 6576-6588, 2017 | 39 | 2017 |
| Co-deleting Pten with Rb in retinal progenitor cells in mice results in fully penetrant bilateral retinoblastomas C Xie, H Lu, A Nomura, EA Hanse, CL Forster, JB Parker, MA Linden, ... Molecular cancer 14, 1-11, 2015 | 34 | 2015 |
| Achieving stringent CR is essential before reduced-intensity conditioning allogeneic hematopoietic cell transplantation in AML C Ustun, AC Wiseman, TE Defor, S Yohe, MA Linden, B Oran, M Burke, ... Bone marrow transplantation 48 (11), 1415-1420, 2013 | 34 | 2013 |
| Assessment of circulating tumor cells as a predictive biomarker of histology in women with suspected ovarian cancer E Lou, RI Vogel, D Teoh, S Hoostal, A Grad, M Gerber, M Monu, ... Laboratory medicine 49 (2), 134-139, 2018 | 33 | 2018 |
| Marked variability in reported minimal residual disease lower level of detection of 4 hematolymphoid neoplasms: a survey of participants in the College of American Pathologists … M Keeney, JG Halley, DD Rhoads, MQ Ansari, SJ Kussick, WJ Karlon, ... Archives of pathology & laboratory medicine 139 (10), 1276-1280, 2015 | 31 | 2015 |
| Secondary cytogenetic abnormalities in core-binding factor AML harboring inv (16) vs t (8; 21) SY Han, K Mrózek, J Voutsinas, Q Wu, EA Morgan, H Vestergaard, ... Blood advances 5 (10), 2481-2489, 2021 | 28 | 2021 |
| ZBTB20 regulates WNT/CTNNB1 signalling pathway by suppressing PPARG during hepatocellular carcinoma tumourigenesis JC To, AP Chiu, BR Tschida, LH Lo, CH Chiu, XX Li, TP Kuka, MA Linden, ... JHEP Reports 3 (2), 100223, 2021 | 27 | 2021 |
| Variability in the laboratory measurement of cytokines: a longitudinal summary of a College of American Pathologists proficiency testing survey V Knight, T Long, QH Meng, MA Linden, DD Rhoads Archives of pathology & laboratory medicine 144 (10), 1230-1233, 2020 | 25 | 2020 |
| Loss of UHRF2 expression is associated with human neoplasia, promoter hypermethylation, decreased 5-hydroxymethylcytosine, and high proliferative activity H Lu, S Bhoopatiraju, H Wang, NP Schmitz, X Wang, MJ Freeman, ... Oncotarget 7 (46), 76047, 2016 | 25 | 2016 |
| Subcutaneous bortezomib is highly effective for pure red cell aplasia after ABO-incompatible haematopoietic stem cell transplantation F Khan, MA Linden, ND Zantek, GM Vercellotti Transfusion medicine (Oxford, England) 24 (3), 187, 2014 | 25 | 2014 |
Brian Van NessUniversity of MinnesotaVerified email at umn.edu
